-
Product Insights
ATP Citrate Synthase – Drugs In Development, 2023
Global Markets Direct’s ATP Citrate Synthase provides in depth analysis on ATP Citrate Synthase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in ATP Citrate Synthase targeted therapeutics...
-
Product Insights
Werner Syndrome ATP Dependent Helicase – Drugs In Development, 2023
Global Markets Direct’s Werner Syndrome ATP Dependent Helicase provides in depth analysis on Werner Syndrome ATP Dependent Helicase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Werner...
-
Product Insights
Retinal Specific ATP Binding Cassette Transporter – Drugs In Development, 2023
Global Markets Direct’s Retinal Specific ATP Binding Cassette Transporter provides in depth analysis on Retinal Specific ATP Binding Cassette Transporter targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Probable ATP Dependent RNA Helicase DDX58 – Drugs In Development, 2023
Global Markets Direct’s Probable ATP Dependent RNA Helicase DDX58 provides in depth analysis on Probable ATP Dependent RNA Helicase DDX58 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial – Drugs In Development, 2023
Global Markets Direct’s ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial provides in depth analysis on ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
ATP Binding Cassette Sub Family A Member 1 – Drugs In Development, 2023
Global Markets Direct’s ATP Binding Cassette Sub Family A Member 1 provides in depth analysis on ATP Binding Cassette Sub Family A Member 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
ATP Sensitive Inward Rectifier Potassium Channel 8 – Drugs In Development, 2023
Global Markets Direct’s ATP Sensitive Inward Rectifier Potassium Channel 8 provides in depth analysis on ATP Sensitive Inward Rectifier Potassium Channel 8 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
ATP Binding Cassette Sub Family C Member 8 – Drugs In Development, 2023
Global Markets Direct’s ATP Binding Cassette Sub Family C Member 8 provides in depth analysis on ATP Binding Cassette Sub Family C Member 8 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
ATP Binding Cassette Sub Family G Member 2 – Drugs In Development, 2023
Global Markets Direct’s ATP Binding Cassette Sub Family G Member 2 provides in depth analysis on ATP Binding Cassette Sub Family G Member 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TIN-816 in Sepsis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TIN-816 in Sepsis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TIN-816 in Sepsis Drug Details: TIN-816 is under development for the treatment of...